D2F™ Glass Vials
NIPRO, a trusted manufacturer of high-quality RTU glass vials, delivers tailored solutions for both conventional and advanced pharmaceutical formulations. Whether for vaccines, biologics, or other sensitive medications, NIPRO’s D2F™ glass vials¹ provide a reliable option for pharmaceutical companies.
D2F™ Vials shorten time to market
For pharmaceutical companies transitioning to RTU vials, D2F™ vials1 eliminate the need for in-house washing and depyrogenation. Ready to use in aseptic environments, they support scalable production—from test batches to commercial volumes. Developed in collaboration with leading machine manufacturers, D2F™ nest and tub formats are compatible with a wide range of fill-finish lines, ensuring smooth and rapid integration.
No glass-to-glass contact improves filling line container performance
D2F™ nest and tub formats prevent glass-to-glass contact, reducing the risk of breakage, cosmetic defects, and particle generation during transport and handling. This protection helps maintain the vials’ mechanical strength and visual quality, resulting in fewer breakages, less downtime on fill-finish lines, and lower rejection rates during final inspection.
Outsourcing of non-core activities improves total cost of ownership
By outsourcing non-core activities for sterile vials to NIPRO, our business partner will save the time and cost involved in preparing RTU containers. Our customers will receive D2F™ vials1 washed, depyrogenated, and sterilized, ready to be used directly in aseptic fill-finish operations.
Standard range
- Crimp neck: 2ml to 100ml (ISO 8362-1 compliant)
- Screw neck: 5ml to 125ml
- Uni-dose: 0,35ml and 0,55ml
- High-recovery vials: 0,66ml to 2,77ml
- Lyophilisation vials
- Bulk | D2F™ (Direct-to-Fill) sterile packaging
- Closures and caps
